Rosás-Umbert, Miriam https://orcid.org/0000-0002-2850-6586
Gunst, Jesper D. https://orcid.org/0000-0002-3787-0259
Pahus, Marie H. https://orcid.org/0000-0003-0776-3847
Olesen, Rikke
Schleimann, Mariane https://orcid.org/0000-0001-5147-9523
Denton, Paul W. https://orcid.org/0000-0003-2458-8147
Ramos, Victor
Ward, Adam https://orcid.org/0000-0002-7038-5597
Kinloch, Natalie N.
Copertino, Dennis C. https://orcid.org/0000-0002-3217-4713
Escribà, Tuixent https://orcid.org/0000-0001-9467-7802
Llano, Anuska https://orcid.org/0000-0002-0133-9888
Brumme, Zabrina L. https://orcid.org/0000-0002-8157-1037
Brad Jones, R. https://orcid.org/0000-0003-4470-1231
Mothe, Beatriz https://orcid.org/0000-0001-9975-407X
Brander, Christian https://orcid.org/0000-0002-0548-5778
Fox, Julie https://orcid.org/0000-0002-0583-8019
Nussenzweig, Michel C. https://orcid.org/0000-0003-0592-8564
Fidler, Sarah
Caskey, Marina https://orcid.org/0000-0003-1727-8693
Tolstrup, Martin
Søgaard, Ole S. https://orcid.org/0000-0001-9107-2023
Funding for this research was provided by:
Det Frie Forskningsråd (7016-00022, 9060-00023B)
Article History
Received: 15 August 2022
Accepted: 14 October 2022
First Online: 29 October 2022
Competing interests
: M.C.N. is listed as an inventor on patents for the antibody 3BNC117. All other authors declare no competing interests.